NCT01039753

Brief Summary

Acute kidney injury is more frequent and the mortality rate would be as high as 50-60% when the renal replacement therapy was needed. Many studies about the timing of start and discontinuation of dialysis, dialysis dose, dialyzer, anticoagulation and dialysates were initiated but the results were still controversial. In addition, more new biomarkers were found to predict the outcome of acute kidney injury and these biomarkers may play an important role for the dilemma of aforementioned studies. This observational prospective study has two objectives:

  1. 1.To find the predictors of outcome for the acute kidney injury with renal replacement therapy and determine the appropriate method.
  2. 2.To find the relationship between new biomarkers and acute kidney injury and determine whether it can be a factor for the monitor of the response of the renal replacement therapy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2010

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 24, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 25, 2009

Completed
7 days until next milestone

Study Start

First participant enrolled

January 1, 2010

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2011

Completed
Last Updated

January 29, 2010

Status Verified

January 1, 2010

Enrollment Period

1.4 years

First QC Date

December 24, 2009

Last Update Submit

January 28, 2010

Conditions

Keywords

acute kidney injuryrenal replacement therapybiomarkers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients older than 18 years-old and admitted to intensive care units of National Taiwan University Hospital

You may qualify if:

  • Patients older than 18 years-old and admitted to intensive care units of National Taiwan University Hospital

You may not qualify if:

  • End stage renal disease
  • Terminal disease with estimated life span shorter than 28 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 10002, Taiwan

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Collect serum and urine sample for biomarkers at the following timing: start date of renal replacement therapy, discontinuation date of renal replacement therapy, 7 days after discontinuation date of renal replacement therapy. 10ml blood and 10ml urine will be collected at each sampling

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Central Study Contacts

Yung-Ming Chen, Ph.D

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 24, 2009

First Posted

December 25, 2009

Study Start

January 1, 2010

Primary Completion

June 1, 2011

Study Completion

July 1, 2011

Last Updated

January 29, 2010

Record last verified: 2010-01

Locations